Conquest Research
Mark Daley is the CEO and Founder of Conquest Research, with previous experience in clinical research coordination at Compass Research - Bioclinica Research Network. Mark has also worked as a Research Coordinator at the University of Florida, focusing on neuroendocrine pancreatic cancer and small cell lung carcinoma research. In addition, Mark has experience as a Biochemistry Teaching Assistant and as a Sales and Marketing Assistant at Pentaho. Mark received their Bachelor of Science in Biology from the University of Florida.
Conquest Research
Conquest Research was formed to offer the most efficient clinical research services to partners and pharmaceutical companies worldwide. With a leader who’s extremely passionate about advancing the clinical trial process through technology, our mission is to deliver high quality clinical research in a cost-effective and timely manner. Conquest Research offers services not only directly to pharmaceutical companies, but also to physician practices interested in conducting clinical trials to offer new and innovative treatment options to their patients.